Helmerich & Payne: UBS initiates coverage with buy rating and $49 target price
HP•UBS initiated coverage of Helmerich & Payne with a buy rating and a $49 target price.
Related News
Flotek updates financial calendar with Q3 2026 earnings release, conference call schedule
FTK•
Castle Biosciences says ACG 2026 data show TissueCypher flags Barrett’s progression risk beyond biopsy findings
CSTL•
Mettler-Toledo to host investor meeting webcast
MTD•
Fed's Hammack hopes to cool demand and inflation without job market pain
TLT•
USANA schedules third-quarter 2026 earnings release and conference call
USNA•